International Journal of Hematology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax
Int J Hematol. 2023 Aug 15. doi: 10.1007/s12185-023-03646-3. Online ahead of print.NO ABSTRACTPMID:37581752 | DOI:10.1007/s12185-023-03646-3 (Source: International Journal of Hematology)
Source: International Journal of Hematology - August 15, 2023 Category: Hematology Authors: Koji Izutsu Kazuhito Yamamoto Koji Kato Takayuki Ishikawa Noriko Fukuhara Yasuhito Terui Ilseung Choi Sumiko Okubo Natsumi Ogawa Mizu Sakai Yasuko Nishimura Brenda Chyla Yan Sun Dai Maruyama Source Type: research

Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax
Int J Hematol. 2023 Aug 15. doi: 10.1007/s12185-023-03646-3. Online ahead of print.NO ABSTRACTPMID:37581752 | DOI:10.1007/s12185-023-03646-3 (Source: International Journal of Hematology)
Source: International Journal of Hematology - August 15, 2023 Category: Hematology Authors: Koji Izutsu Kazuhito Yamamoto Koji Kato Takayuki Ishikawa Noriko Fukuhara Yasuhito Terui Ilseung Choi Sumiko Okubo Natsumi Ogawa Mizu Sakai Yasuko Nishimura Brenda Chyla Yan Sun Dai Maruyama Source Type: research

Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax
Int J Hematol. 2023 Aug 15. doi: 10.1007/s12185-023-03646-3. Online ahead of print.NO ABSTRACTPMID:37581752 | DOI:10.1007/s12185-023-03646-3 (Source: International Journal of Hematology)
Source: International Journal of Hematology - August 15, 2023 Category: Hematology Authors: Koji Izutsu Kazuhito Yamamoto Koji Kato Takayuki Ishikawa Noriko Fukuhara Yasuhito Terui Ilseung Choi Sumiko Okubo Natsumi Ogawa Mizu Sakai Yasuko Nishimura Brenda Chyla Yan Sun Dai Maruyama Source Type: research

Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax
Int J Hematol. 2023 Aug 15. doi: 10.1007/s12185-023-03646-3. Online ahead of print.NO ABSTRACTPMID:37581752 | DOI:10.1007/s12185-023-03646-3 (Source: International Journal of Hematology)
Source: International Journal of Hematology - August 15, 2023 Category: Hematology Authors: Koji Izutsu Kazuhito Yamamoto Koji Kato Takayuki Ishikawa Noriko Fukuhara Yasuhito Terui Ilseung Choi Sumiko Okubo Natsumi Ogawa Mizu Sakai Yasuko Nishimura Brenda Chyla Yan Sun Dai Maruyama Source Type: research

Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax
Int J Hematol. 2023 Aug 15. doi: 10.1007/s12185-023-03646-3. Online ahead of print.NO ABSTRACTPMID:37581752 | DOI:10.1007/s12185-023-03646-3 (Source: International Journal of Hematology)
Source: International Journal of Hematology - August 15, 2023 Category: Hematology Authors: Koji Izutsu Kazuhito Yamamoto Koji Kato Takayuki Ishikawa Noriko Fukuhara Yasuhito Terui Ilseung Choi Sumiko Okubo Natsumi Ogawa Mizu Sakai Yasuko Nishimura Brenda Chyla Yan Sun Dai Maruyama Source Type: research